Nuclear Imaging Equipment Market Size

Nuclear Imaging Equipment Market size was valued at USD 3.25 Billion in 2023 and is poised to grow from USD 3.49 Billion in 2024 to USD 6.18 Billion by 2032, growing at a CAGR of 7.41% during the forecast period (2025-2032).

The global nuclear imaging equipment market is a highly competitive global market driven by many international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Siemens AG ', 'General Electric ', 'Koninklijke Philips N.V. ', 'TTG Imaging Solutions ', 'Neusoft Corporation ', 'Canon Inc. ', 'Surgiceye GmbH ', 'Bozlu Holding ', 'CMR Naviscan Corporation ', 'Mediso Ltd. ', 'Shimadzu Corporation ', 'Revvity Inc ', 'Rigaku ', 'MR Solutions Ltd.    ', 'Agfa-Gevaert N.V ', 'Medtronic plc ', 'Bracco Group ', 'Cubresa Inc. ', 'Jubilant Radiopharma ', 'South African Nuclear Energy Corporation (Necsa)'

The emergence of hybrid systems, such as PET/MRI and PET/CT blends the powers of diverse imaging modalities, offering higher precision and exhaustive diagnostic details. The awareness and growing significance of these imaging systems is propelling market growth. Also, improvements in radiopharmaceuticals enhance accuracy of imaging and widen the number of conditions with nuclear imaging, impacting the market growth.

Progress in Radiopharmaceuticals: Modernizations in radiopharmaceuticals are widening the number of diseases that can be effectively diagnosed with advanced nuclear imaging. Novel tracers and currently being improved for certain cancer types, cardiovascular disease, and neurological disorders. Also, the combination of targeted therapy with diagnostic imaging known as theragnostic is gaining popularity. It specializes in treating oncological diseases.

Region-wise, North America is the dominating region among others and is expected to lead over the forecast period owing to its state-of-art technologies and the growing cases of chronic illnesses. The region has high-tech healthcare infrastructure with several improved diagnostic services and healthcare settings equipped with modern nuclear imaging tools. Moreover, the region tops in the implementation of the latest technologies and upgrades like superior nuclear imaging, impacted by constant research and innovations. The region also holds a larger number of nuclear imaging suppliers and manufacturers, supporting the market growth. The key players operating in the region include GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems USA, Lantheus Medical Imaging, and more.